Correlation Between Arbutus Biopharma and ACADIA Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and ACADIA Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and ACADIA Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arbutus Biopharma Corp and ACADIA Pharmaceuticals, you can compare the effects of market volatilities on Arbutus Biopharma and ACADIA Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of ACADIA Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and ACADIA Pharmaceuticals.
Diversification Opportunities for Arbutus Biopharma and ACADIA Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Arbutus and ACADIA is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and ACADIA Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACADIA Pharmaceuticals and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with ACADIA Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACADIA Pharmaceuticals has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and ACADIA Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arbutus Biopharma and ACADIA Pharmaceuticals
Given the investment horizon of 90 days Arbutus Biopharma Corp is expected to generate 3.03 times more return on investment than ACADIA Pharmaceuticals. However, Arbutus Biopharma is 3.03 times more volatile than ACADIA Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. ACADIA Pharmaceuticals is currently generating about -0.2 per unit of risk. If you would invest 249.00 in Arbutus Biopharma Corp on January 24, 2024 and sell it today you would earn a total of 26.00 from holding Arbutus Biopharma Corp or generate 10.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Arbutus Biopharma Corp vs. ACADIA Pharmaceuticals
Performance |
Timeline |
Arbutus Biopharma Corp |
ACADIA Pharmaceuticals |
Arbutus Biopharma and ACADIA Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arbutus Biopharma and ACADIA Pharmaceuticals
The main advantage of trading using opposite Arbutus Biopharma and ACADIA Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, ACADIA Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will offset losses from the drop in ACADIA Pharmaceuticals' long position.Arbutus Biopharma vs. VBI Vaccines | Arbutus Biopharma vs. ADMA Biologics | Arbutus Biopharma vs. Adaptimmune Therapeutics Plc | Arbutus Biopharma vs. Affimed NV |
ACADIA Pharmaceuticals vs. Madrigal Pharmaceuticals | ACADIA Pharmaceuticals vs. Viking Therapeutics | ACADIA Pharmaceuticals vs. Sarepta Therapeutics | ACADIA Pharmaceuticals vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stocks Directory Find actively traded stocks across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |